Transverse myelitis (TM) is a very rare complication of systemic lupus erythematosus (SLE) and its prognosis is poor. It therefore needs to be treated aggressively. We describe a patient suffering from SLE associated with TM, who responded well to a combination of immunoadsorption therapy and steroid mini-pulse therapy. His serum interleukin 6 levels as well as clinical indicators fell to normal after this treatment.
KlaimanM.D., MillerS.D.. Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine.Am J Phys Med Rehabil1993; 72: 158–61.
3.
BarileL., LavalleC.. Transverse myelitis in systemic lupus erythematosus - the effect of IV pulse methylprednisolone and cyclophosphamide.J Rheumatol1992; 19: 370–2.
4.
Simeon-AznarC.P., Tolosa-VilellaC., Cuenca-LuqueR., Jordana-ComajuncosaR., Ordi-RosJ., Bosch-GilJ.A.. Transverse myelitis in systemic lupus erythematosus: two cases with magnetic resonance imaging.Br J Rheumatol1992; 31: 555–8.
5.
EulerH.H., SchroederJ.O., HartenP., ZeunerR.A., GutschmidtH.J.. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide.Arthritis Rheum1994; 37: 1784–94.
6.
NeuweltC.M., LacksS., KayeB.R., EllmanJ.B., BorensteinD.G.. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus.Am J Med1995; 98: 32–41.
7.
LlorenteL., Richaud-PatinY., FiorR.In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus.Arthritis Rheum1994; 37: 1647–55.
8.
SandsM.L., RyczakM., BrownR.B.. Recurrent aseptic meningitis followed by transverse myelitis as a presentation of systemic lupus erythematosus.J Rheumatol1988; 15: 862–4.
9.
SchroederJ.O., EulerH.H., LöfflerH.. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.Ann Int Med1987; 107: 344–6.
10.
SuzukiK., HaraM., HarigaiM.Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus.Arthritis Rheumatol1991; 34: 1546–52.
11.
MuramatsuM., FukushimaA., KanayamaH.Three case reports of systemic lupus erythematosus responsive to extracorporeal immunoadsorption therapy.Jpn J Apheresis1994; 13: 129–30.
